ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,387, issued on May 27, was assigned to UNIVERSITAT ULM (Ulm, Germany).
"Complement inhibitors and uses thereof" was invented by Christoph Schmidt (Westerheim, Germany), Hubert Schrezenmeier (Ulm, Germany), Markus Anliker (Amstetten, Germany) and Britta Hoechsmann (Friedrichshafen, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a multi-domain polypeptide comprising (i) a first complement control protein repeat (CCP)-comprising domain being a convertase decay accelerating domain for convertases of the classical and alternative pathways of complement activation, (ii) a host cell recognition domain, and (iii) a s...